Bedrijfstakpensioenfonds Voor DE Media PNO Holds Position in Medtronic PLC (MDT)

Bedrijfstakpensioenfonds Voor DE Media PNO continued to hold its position in shares of Medtronic PLC (NYSE:MDT) during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 14,300 shares of the medical technology company’s stock at the end of the first quarter. Bedrijfstakpensioenfonds Voor DE Media PNO’s holdings in Medtronic PLC were worth $1,152,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in MDT. Ally Financial Inc. bought a new position in shares of Medtronic PLC during the fourth quarter valued at about $2,493,000. Motley Fool Wealth Management LLC raised its position in shares of Medtronic PLC by 1.7% in the fourth quarter. Motley Fool Wealth Management LLC now owns 98,910 shares of the medical technology company’s stock valued at $7,045,000 after buying an additional 1,637 shares in the last quarter. State Street Corp raised its position in shares of Medtronic PLC by 2.4% in the fourth quarter. State Street Corp now owns 64,040,900 shares of the medical technology company’s stock valued at $4,564,431,000 after buying an additional 1,481,108 shares in the last quarter. Cipher Capital LP raised its position in shares of Medtronic PLC by 845.0% in the fourth quarter. Cipher Capital LP now owns 139,807 shares of the medical technology company’s stock valued at $9,959,000 after buying an additional 125,012 shares in the last quarter. Finally, Tredje AP fonden raised its position in shares of Medtronic PLC by 12.5% in the fourth quarter. Tredje AP fonden now owns 165,137 shares of the medical technology company’s stock valued at $11,834,000 after buying an additional 18,318 shares in the last quarter. 82.53% of the stock is owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for Medtronic PLC (NYSE:MDT)

Shares of Medtronic PLC (NYSE:MDT) opened at 87.63 on Tuesday. The company has a 50-day moving average price of $84.19 and a 200-day moving average price of $78.90. Medtronic PLC has a 12 month low of $69.35 and a 12 month high of $89.27. The company has a market capitalization of $119.97 billion, a price-to-earnings ratio of 30.32 and a beta of 1.04.

Medtronic PLC (NYSE:MDT) last released its quarterly earnings results on Thursday, May 25th. The medical technology company reported $1.33 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.31 by $0.02. Medtronic PLC had a net margin of 13.56% and a return on equity of 12.72%. The company had revenue of $7.92 billion during the quarter, compared to the consensus estimate of $7.86 billion. During the same period in the prior year, the firm earned $1.27 earnings per share. Medtronic PLC’s revenue was up 4.6% on a year-over-year basis. On average, equities analysts anticipate that Medtronic PLC will post $4.95 EPS for the current year.

WARNING: “Bedrijfstakpensioenfonds Voor DE Media PNO Holds Position in Medtronic PLC (MDT)” was reported by Mideast Time and is owned by of Mideast Time. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.mideasttime.com/bedrijfstakpensioenfonds-voor-de-media-pno-holds-position-in-medtronic-plc-mdt/1775270.html.

MDT has been the subject of several analyst reports. Needham & Company LLC raised their target price on Medtronic PLC from $84.00 to $91.00 and gave the stock a “buy” rating in a research report on Tuesday, February 21st. Wedbush reaffirmed a “neutral” rating and set a $85.00 target price on shares of Medtronic PLC in a research report on Wednesday, February 22nd. Jefferies Group LLC reaffirmed a “buy” rating and set a $88.00 target price on shares of Medtronic PLC in a research report on Friday, February 17th. Evercore ISI raised their target price on Medtronic PLC from $78.00 to $88.00 and gave the stock a “buy” rating in a research report on Tuesday, February 21st. Finally, Vetr lowered Medtronic PLC from a “buy” rating to a “hold” rating and set a $80.67 target price for the company. in a research report on Thursday, February 16th. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and fourteen have issued a buy rating to the company’s stock. Medtronic PLC presently has an average rating of “Hold” and a consensus price target of $89.50.

In related news, EVP Hoedt Rob Ten sold 50,757 shares of the stock in a transaction dated Monday, March 20th. The shares were sold at an average price of $81.58, for a total value of $4,140,756.06. Following the completion of the transaction, the executive vice president now directly owns 59,392 shares of the company’s stock, valued at $4,845,199.36. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Omar Ishrak sold 95,000 shares of the stock in a transaction dated Wednesday, March 15th. The stock was sold at an average price of $82.82, for a total transaction of $7,867,900.00. Following the completion of the transaction, the chief executive officer now directly owns 645,616 shares of the company’s stock, valued at $53,469,917.12. The disclosure for this sale can be found here. 0.25% of the stock is owned by corporate insiders.

About Medtronic PLC

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “MDT”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT).

Receive News & Ratings for Medtronic PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic PLC and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.